Canopy Growth (TSX: WEED)
Canopy Growth Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Canopy Growth Company Info
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
News & Analysis
2 Years Later, Cannabis 2.0 Isn't Saving Canopy Growth
This Canadian pot company was the first to impress customers with cannabis derivatives, so what went wrong?
2 Best Cannabis Stocks to Buy in October
Aphria and Charlotte's Web Holdings are both outstanding long-term growth vehicles. Here's why.
2 Top Pot Stocks That Could Vanish by 2024
With big money flowing in from the sidelines, these two pot companies are likely to be the first to be acquired.
Why Canopy Growth Stock Popped 10% on Friday
Piper Jaffray gets (even more) bullish on the cannabis company.
3 Top Marijuana Stocks to Watch in January
These three companies look well positioned to navigate the ever-evolving legislative status surrounding marijuana.
Why Canopy Growth Corporation, Cronos Group, and Tilray Are Sinking Again Today
Canadian pot stocks are getting walloped again today. Here's why.
Better Buy: OrganiGram Holdings Inc. vs. Aurora Cannabis
Which of these top pot stocks is the better buy right now?
Have These Top Marijuana Stocks Already Peaked?
Canopy Growth Corporation, Cronos Group, and Tilray have all seen their stocks explode higher upon their recent uplistings. Can these top pot stocks maintain this momentum -- or is it time to take profits?
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.